Movatterモバイル変換


[0]ホーム

URL:


GB2196853A - Tissue stimulator - Google Patents

Tissue stimulator
Download PDF

Info

Publication number
GB2196853A
GB2196853AGB08610192AGB8610192AGB2196853AGB 2196853 AGB2196853 AGB 2196853AGB 08610192 AGB08610192 AGB 08610192AGB 8610192 AGB8610192 AGB 8610192AGB 2196853 AGB2196853 AGB 2196853A
Authority
GB
United Kingdom
Prior art keywords
tissue
magnetic
stimulator
systems
magnetic field
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08610192A
Other versions
GB8610192D0 (en
Inventor
Karl Adrian Gehring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Company PLC
Original Assignee
General Electric Company PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Electric Company PLCfiledCriticalGeneral Electric Company PLC
Priority to GB08610192ApriorityCriticalpatent/GB2196853A/en
Publication of GB8610192D0publicationCriticalpatent/GB8610192D0/en
Publication of GB2196853ApublicationCriticalpatent/GB2196853A/en
Withdrawnlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

A magnetic tissue stimulator includes a number of magnetic fields coil systems, each system being energisable to produce an extended region of magnetic field maximum. The systems are arranged such that the extended regions intersect in a predetermined region. The coil systems are sequentially energised such that tissue located within the predetermined region is selectively stimulated. <IMAGE>

Description

SPECIFICATIONTissue stimulatorThis invention relates to tissue stimulators.
The use of electrical tissue stimulators for stimulating human or animal tissue by the passage of electrical currents through the tissue for both diagnostic and therapeutic purposes is well known. Such electrical stimulators suffer the disadvantages however that careful placement of the surface electrodes of the stimulator on a patient is required, there is inevitably a high density of current flowing in the tissues of the patient between the electrodes which may cause pain in the patient and it is difficult to electrically stimulate deep lying tissues within the patient. Recently a number of magnetic tissue stimulators have been developed which eliminate some of the problems inherent in electrical tissue stimilators.Examples of such magnetic tissue stimulators are shown in respective articles in TheLancet, pages 1 106~1 107 published on May 11th, 1985 and in Journal of Physics E, volume 18, pages 74-78 published in 1985.
These articles each describe a surface coil which is placed on a surface of a patient so as to apply a varying magnetic field to the part of the patient adjacent to the coil. This then causes an induced current within the tissues of the part to be generated, thereby stimulating the tissues. The use of such magnetic stimulators does not require placement of surface electrodes on the patient, and is pain free to the patient.
Such known magnetic tissue stimulators suffer the disadvantage however that the stimulation is spatially non-selective being strongest within the surface tissues of the patient and decreasing as a function of distance away from the surface of the patient.
It is an object of the present invention to provide a magnetic tissue stimulator wherein this problem. is at least alleviated.
According to the present invention a magnetic tissue stimulator comprises a plurality of magnetic field coil systems, each system being energisable to produce an extended region of magnetic field maximum, the systems being arranged such that the extended regions intersect in a predetermined region, and means for sequentially energising the coil systems such that in use of the stimulator tissue located within said predeteremined region is selectively stimulated.
Two tissue stimulators in accordance with the invention will now be described by way of example only, with reference to the accompanying drawings in which:.
Figure 1 is a schematic diagram of a magnetic field coil system incorporated in the first tissue stimulator, together with the magnetic field profile produced by the coil system as a function of the distance along a direction perpendicular to the axis of the coil system, andFigure 2 is a schematic diagram of the magnetic field coil system incorporated in the second tissue stimulator, together with the magnetic field profile produced by the coil system as a function. of the distance along a direction perpendicular to the axis of the coil system.
Referring firstly to Figure 1, the first tissue stimulator to be described includes two magnetic field coil systems of the form indicated in the figure. Each system comprises three annular magnetic field coils 1, 3, 5 arranged in a parallel spaced configuration along a common axis 7. The outermost coils, 1 5 are connected in the same sense to a power supply (not shown), whilst the central coil 3 is connected to the supply in the opposite sense to that of the coils 1, 5. Each system is designed such that when it is energised by the supply an axial magnetic field is produced by the system whose magnetic flux density B varies with distance r from the axis 7 in the manner indicated in Figure 1, the flux density falling rapidly in the direction away from the axis 7. This field profile is maintained for a distance along the axis 7 such that there exists a linearly extended field maximum.The two coil systems within the stimulator are arranged such that their regions of field maxima intersect to define a localised region.
In use of the tissue stimulator, a patient is positioned such that the tissue of interest within the patient lies within the region of intersection of the regions of field maxima of the two coil systems. The magnetic coil systems are sequentially energised by the power supply such that two magnetic field pulses are produced in rapid succession, one pulse being produced by each system. The strength and duration of each of the pulses are chosen such that the product of the strength and the duration of each pulse on its own is less than the threshold value for stimulation of the tissue. Since the effect of successive pulses is cumulative a second pulse will cause the threshold value to be reached but only within the region of intersection of the regions of field maxima for the two coil systems.
Thus selective stimulation of the tissue of interest will occur.
The threshold value for stimulation will vary widely between tissue types, but generally magnetic field pulses with a peak value in the range 1 to 10 tesla, the duration of the two pulses together being in the range of 50 microseconds to 100 milliseconds will be adequate to induce sufficient current within the tissue to produce stimulation of the tissue.
Such magnetic field pulses would correspond to current densities of between 1 to 100 amps per square metre within the tissue. It will be appreciated that if application of the second pulse after the first pulse is delayed the effect of the first pulse will be attenuated with time. Generally the time allowed to elapse between the application of the two pulses will be in the range 10 microseconds to 10 milliseconds.
The tissue stimulator described above also finds particular application in the selective excitation of tissues which are especially responsive to respective excitation at a particular frequency, for example in the stimulation of the tissue of the cortex or deeper structures, such stimulation being required during neurosurgical operations. The stimulation of such tissue may be achieved by repetitively pulsing each of the two coil systems at the same frequency, usually within the range 1 to 100 Hertz, the pulse widths each being in the range 50 to 100 milliseconds, The relative timing of the pulses produced by each of the two coil systems is chosen such that the pulses are approximately evenly interleaved the overall pulse frequency being chosen to correspond to the particular frequency to which the tissue of interest is especially responsive.The tissue of interest will again be located within the region of intersection of the regions of field maxima of the two coil systems. Thus in this manner the tissue within the region of intersection of the regions of field maxima of the two coil systems will be selectively stimulated at the overall frequency of the pulses from the two coil systems. Tissue outside this region will experience smaller magnetic fields, and/or fields of the lower frequency represented by the pulses from only one of the coil systems.
Turning now to Figure 2, the second tissue stimulator to be described operates on the same general princicples at the first tissue stimulator described above, but incorporates two magnetic field coil systems of the alternative form indicated in this figure. Each coil system comprises two annular magnetic field coils 11, 13 arranged in a parallel spaced configuration along a common axis 15. The coils11, 13 are connected in opposite sense to a power supply (not shown). Each coil system is designed such that when it is energised by the supply, a radial magnetic field is produced in the plane 18 halfway between the coils 11,13, whose field maximum takes the form of an annulus surrounding the coils 11, 13 as indicated in the magnetic flux density B. distance r from the axis 15 plot shown in Figure 2.The two coil systems within the stimulator are again arranged such that the regions of their field maxima intersect, such that by sequential energisation of the two coil systems tissue placed within the region of intersection may be selectively stimulated.
It will be appreciated that whilst in the two magnetic tissue stimulators described herebefore by way of example, each stimulator incorporates two magnetic field coil systems each producing an extended region of magnetic field maximum a magnetic tissue stimulator in accordance with the invention may incorporate three or more such systems, these systems being arranged such that the regions of their field maxima intersect.
It will also be appreciated that whilst in the two magnetic tissues stimulators described herebefore by way of example, each coil system within the stimulator is of similar form, the coil systems may be of different form, as long as it is possible to arrange for their regions of field maxima to intersect to define a localised volume of space.
It will also be appreciate that many other coil systems may be used in a magnetic tissue stimulator in accordance with the invention. Such systems could include a number of coils which are not aligned along a common axis, or are tilted with respect to each other, to produce regions of maximum field extending along straight or curved paths.

Claims (2)

GB08610192A1986-04-251986-04-25Tissue stimulatorWithdrawnGB2196853A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
GB08610192AGB2196853A (en)1986-04-251986-04-25Tissue stimulator

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB08610192AGB2196853A (en)1986-04-251986-04-25Tissue stimulator

Publications (2)

Publication NumberPublication Date
GB8610192D0 GB8610192D0 (en)1986-05-29
GB2196853Atrue GB2196853A (en)1988-05-11

Family

ID=10596857

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB08610192AWithdrawnGB2196853A (en)1986-04-251986-04-25Tissue stimulator

Country Status (1)

CountryLink
GB (1)GB2196853A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB2271931A (en)*1992-10-291994-05-04Benjamin Israel SacksMagnetic stimulator for medical use
GB2371203A (en)*2001-01-232002-07-24Univ BristolMethod and apparatus for rendering an animal insensible
EP1890762B1 (en)*2005-06-162020-12-02Brainsway, Inc.Transcranial magnetic stimulation system

Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1592999A (en)*1976-09-271981-07-15Leveen H HApparatus for the application of rf energy to biological substrates in human and/or animal therapy
GB1595108A (en)*1977-11-041981-08-05Kalfaian M VApparatus for treating biological ailments
US4397314A (en)*1981-08-031983-08-09Clini-Therm CorporationMethod and apparatus for controlling and optimizing the heating pattern for a hyperthermia system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1592999A (en)*1976-09-271981-07-15Leveen H HApparatus for the application of rf energy to biological substrates in human and/or animal therapy
GB1595108A (en)*1977-11-041981-08-05Kalfaian M VApparatus for treating biological ailments
US4397314A (en)*1981-08-031983-08-09Clini-Therm CorporationMethod and apparatus for controlling and optimizing the heating pattern for a hyperthermia system

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB2271931A (en)*1992-10-291994-05-04Benjamin Israel SacksMagnetic stimulator for medical use
GB2371203A (en)*2001-01-232002-07-24Univ BristolMethod and apparatus for rendering an animal insensible
EP1890762B1 (en)*2005-06-162020-12-02Brainsway, Inc.Transcranial magnetic stimulation system

Also Published As

Publication numberPublication date
GB8610192D0 (en)1986-05-29

Similar Documents

PublicationPublication DateTitle
Ueno et al.Localized stimulation of neural tissues in the brain by means of a paired configuration of time‐varying magnetic fields
AU5241699A (en)Pemf treatment for osteoporosis and tissue growth stimulation
EP1606013B1 (en)Reducing discomfort caused by electrical stimulation
JP5706334B2 (en) System and method for control of electric field pulse parameters using transcranial magnetic stimulation
DE202019100003U1 (en) Magnetic field generating device for treating a patient
US5738625A (en)Method of and apparatus for magnetically stimulating neural cells
CS205096B2 (en)Device for cultivating the live cells and tissues
EP0617982A1 (en)Method and apparatus for neuromagnetical stimulation
WO2009020938A1 (en)Monophasic multi-coil arrays for trancranial magnetic stimulation
CA1177895A (en)Apparatus for enhancement of in-vivo anti-cancer drug therapy
GB2196853A (en)Tissue stimulator
Yamaguchi et al.Electromagnetic mechanism of magnetic nerve stimulation
Ilmoniemi et al.Transcranial magnetic stimulation coils
DE3046765A1 (en)Combined magnetic pole acupuncture instrument - has pointed bar electromagnet which also measures skin resistance
RU96104755A (en) METHOD FOR TREATING NEURITIS, HYPOXIA AND PARTIAL ATROPHY OF NERVOUS FIBERS AND A DEVICE FOR ITS IMPLEMENTATION
DE3403786A1 (en)Magnetic field therapy device with matrix coils
ReillyStimulation via electric and magnetic fields
Al-Mutawaly et al.Magnetic nerve stimulation: Field focality and depth of penetration
JP7189594B2 (en) Non-invasive human dominant hemisphere cerebral motor language area determination device
RU2192212C1 (en)Device for performing magnetic stimulation of optic nerve and tract
DimitrovA Stimulation of Neural Tissue by Pulse Magnetic Signals
Zyss et al.Developing magnetic stimulator for rapid rate TMS: theoretical and practical problems
EATONMagnetic Nerve Stimulation
JPH04170969A (en)Magnetic medical treatment device for treating fracture
Krawczyk et al.Computer modeling of (electro) magnetic field during stimulation of human brain

Legal Events

DateCodeTitleDescription
WAPApplication withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)

[8]ページ先頭

©2009-2025 Movatter.jp